Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

22 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Southwest Oncology Group S0421 Symptom Questionnaires: Step 1 Randomization Form NCT00134056

- 12/6/15 - 1 formulario, 1 itemgroup, 30 items, 1 idioma
Itemgroup: SWOG clinical trial symptom questionnaire
Southwest Oncology Group S0421 Symptom Questionnaires: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B296A-D2C9-33BF-E034-0003BA3F9857

Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 2 Post-Chemo Form NCT00134056

- 12/6/15 - 1 formulario, 2 itemgroups, 20 items, 1 idioma
Itemgroups: SWOG clinical trial administrative data, Comments
Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D56C4-48DA-2FAB-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form - 2464820v1.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form

- 9/1/15 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Header, ADVERSE EVENTS, Comments
SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D4F4F-BA23-2F60-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization - 2305232v3.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization

- 9/1/15 - 1 formulario, 3 itemgroups, 20 items, 1 idioma
Itemgroups: Header, ADVERSE EVENTS, Comments
SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B0C64-8BEB-3314-E034-0003BA3F9857

Prostate Cancer NCT00079001 On-Study - CALGB 90202: Skeletal Survey Form - 2083769v3.0 - CALGB 90202: Skeletal Survey Form

- 9/1/15 - 1 formulario, 1 itemgroup, 22 items, 1 idioma
Itemgroup: CCRR MODULE
CALGB 90202: Skeletal Survey Form Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7BE7E12-C8DF-7003-E034-0003BA12F5E7

Metastatic Cancer NCT00134056 Response - Southwest Oncology Group - Bisphosphonate Usage Form - 2759910v1.0 - Southwest Oncology Group - Bisphosphonate Usage Form

- 9/1/15 - 1 formulario, 3 itemgroups, 19 items, 1 idioma
Itemgroups: Header, Header, Comments
Southwest Oncology Group - Bisphosphonate Usage Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FD609AB-09CA-1C94-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Response - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM - 2304629v3.0 - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM

- 9/1/15 - 1 formulario, 3 itemgroups, 12 items, 1 idioma
Itemgroups: Header, PSA MEASUREMENTS, Comments
SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159832A-A1FF-27F6-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Pre-Study - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421) - 2306139v3.0 - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421)

- 9/1/15 - 1 formulario, 8 itemgroups, 79 items, 1 idioma
Itemgroups: Header, PATIENT AND DISEASE DESCRIPTION, Laboratory Values, Associated Correlative Science Consent, Additional Prestudy Data, DISTANT METASTATIC DISEASE, Prior Treatment Related To This Cancer, Comments
SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421) Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F1F9786C-0716-36C3-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Follow-Up - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM - 2305135v3.0 - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM

- 9/1/15 - 1 formulario, 3 itemgroups, 27 items, 1 idioma
Itemgroups: Header, VITAL STATUS, Comments
SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159EF7E-D486-319F-E034-0003BA3F9857

Eligibility NCT00321464 Bone Metastases in Subjects With Advanced Breast Cancer - Eligibility

- 14/4/14 - 1 formulario, 2 itemgroups, 8 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00321464

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial